Literature DB >> 2037101

Resectoscopic myomectomy.

S L Corson1, P G Brooks.   

Abstract

OBJECTIVE: To evaluate safety and efficacy of resectoscopic myomectomy for control of menorrhagia, dysmenorrhea, and/or reproductive wastage.
DESIGN: Retrospective consecutive patient follow-up.
SETTING: Private practice, outpatient, hospital. PATIENTS: All patients (92) having resectoscopic myomectomy between September 1, 1986 and December 31, 1989.
INTERVENTIONS: Resectoscopic myomectomy with or without concomitant procedures such as endometrial ablation. MAIN OUTCOME MEASURES: Assessment of dysmenorrhea, menorrhagia, and reproductive outcome after surgery.
RESULTS: Elimination of dysmenorrhea in 24 of 28, absence of menorrhagia in 65 of 80, and pregnancy in 10 of 13 with two abortions in a total of 11 gestations. One patient was admitted and treated with one unit of autologous blood and mechanical tamponade with an intrauterine balloon. Three cases of uterine perforation had no sequelae. One patient had mild endometritis responding to outpatient antibiotics. Two cases of leiomyosarcoma were diagnosed histologically and accounted for two of the three hysterectomies noted during follow-up.
CONCLUSIONS: Resectoscopic myomectomy is a safe, effective, and relatively simple outpatient surgical procedure.

Entities:  

Mesh:

Year:  1991        PMID: 2037101     DOI: 10.1016/s0015-0282(16)54349-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

Review 1.  [Hysteroscopic surgery].

Authors:  R Kimmig
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

Review 2.  Lasers in endoscopic surgery.

Authors:  T Gyr; S Spörri; M Frenz; H J Altermatt; A W Brandenberger; E Dreher
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

3.  Does "no-touch" technique hysteroscopy increase the risk of infection?

Authors:  Evrim Ebru Kovalak
Journal:  Turk J Obstet Gynecol       Date:  2022-06-27

4.  Hydrothermal endometrial ablation can reduce the need for hysterectomy and transfusion.

Authors:  Herbert A Goldfarb; Michelle Hanes; Farzaneh Nabizadeh
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

Review 5.  Surgical treatment for chronic pelvic pain.

Authors:  J E Carter
Journal:  JSLS       Date:  1998 Apr-Jun       Impact factor: 2.172

6.  Hysteroscopic myomectomy: our experience and review.

Authors:  J L Muñoz; J S Jiménez; C Hernández; G Vaquero; C Pérez Sagaseta; R Noguero; P Miranda; J M Hernández; P De la Fuente
Journal:  JSLS       Date:  2003 Jan-Mar       Impact factor: 2.172

7.  Do submucous myoma characteristics affect fertility and menstrual outcomes in patients underwent hysteroscopic myomectomy?

Authors:  Ahmed Namazov; Resul Karakus; Ezgi Gencer; Hamdullah Sozen; Levent Acar
Journal:  Iran J Reprod Med       Date:  2015-06

Review 8.  The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis.

Authors:  Elizabeth A Pritts; David J Vanness; Jonathan S Berek; William Parker; Ronald Feinberg; Jacqueline Feinberg; David L Olive
Journal:  Gynecol Surg       Date:  2015-05-19

9.  Submucous fibroids and infertility: Effect of hysteroscopic myomectomy and factors influencing outcome.

Authors:  K Jayakrishnan; Vandana Menon; Divya Nambiar
Journal:  J Hum Reprod Sci       Date:  2013-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.